(1S,2S,3S,4R)-3-[3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl]-N-(pyridin-3-ylmethyl)bicyclo[2.2.1]heptane-2-carboxamide

C23H24N4O3 — CID 171336851

IUPAC(1S,2S,3S,4R)-3-[3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl]-N-(pyridin-3-ylmethyl)bicyclo[2.2.1]heptane-2-carboxamide
SMILESO=C(NCc1cccnc1)[C@H]1[C@H]2CC[C@H](C2)[C@@H]1c1nc(COc2ccccc2)no1
InChIInChI=1S/C23H24N4O3/c28-22(25-13-15-5-4-10-24-12-15)20-16-8-9-17(11-16)21(20)23-26-19(27-30-23)14-29-18-6-2-1-3-7-18/h1-7,10,12,16-17,20-21H,8-9,11,13-14H2,(H,25,28)/t16-,17+,20-,21-/m0/s1
InChIKeyHEEKTMQRLKRHIL-JWWGGVBKSA-N
MW404.47 g/mol
LogP3.49
Rot. Bonds7

About (1S,2S,3S,4R)-3-[3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl]-N-(pyridin-3-ylmethyl)bicyclo[2.2.1]heptane-2-carboxamide

(1S,2S,3S,4R)-3-[3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl]-N-(pyridin-3-ylmethyl)bicyclo[2.2.1]heptane-2-carboxamide (PubChem CID 171336851) has the molecular formula C23H24N4O3 and a molecular weight of 404.47 g/mol. Its IUPAC name is (1S,2S,3S,4R)-3-[3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl]-N-(pyridin-3-ylmethyl)bicyclo[2.2.1]heptane-2-carboxamide.

Molecular Properties

Compound Name(1S,2S,3S,4R)-3-[3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl]-N-(pyridin-3-ylmethyl)bicyclo[2.2.1]heptane-2-carboxamide
PubChem CID171336851
Molecular FormulaC23H24N4O3
Molecular Weight404.47 g/mol
Exact Mass404.18
IUPAC Name(1S,2S,3S,4R)-3-[3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl]-N-(pyridin-3-ylmethyl)bicyclo[2.2.1]heptane-2-carboxamide
SMILESO=C(NCc1cccnc1)[C@H]1[C@H]2CC[C@H](C2)[C@@H]1c1nc(COc2ccccc2)no1
InChIInChI=1S/C23H24N4O3/c28-22(25-13-15-5-4-10-24-12-15)20-16-8-9-17(11-16)21(20)23-26-19(27-30-23)14-29-18-6-2-1-3-7-18/h1-7,10,12,16-17,20-21H,8-9,11,13-14H2,(H,25,28)/t16-,17+,20-,21-/m0/s1
InChIKeyHEEKTMQRLKRHIL-JWWGGVBKSA-N
XLogP3.49
TPSA90.14 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500404.47
LogP ≤ 53.49
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze (1S,2S,3S,4R)-3-[3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl]-N-(pyridin-3-ylmethyl)bicyclo[2.2.1]heptane-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (1S,2S,3S,4R)-3-[3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl]-N-(pyridin-3-ylmethyl)bicyclo[2.2.1]heptane-2-carboxamide?
The IUPAC name of (1S,2S,3S,4R)-3-[3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl]-N-(pyridin-3-ylmethyl)bicyclo[2.2.1]heptane-2-carboxamide (CID 171336851) is (1S,2S,3S,4R)-3-[3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl]-N-(pyridin-3-ylmethyl)bicyclo[2.2.1]heptane-2-carboxamide.
What is the SMILES notation for (1S,2S,3S,4R)-3-[3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl]-N-(pyridin-3-ylmethyl)bicyclo[2.2.1]heptane-2-carboxamide?
The canonical SMILES for (1S,2S,3S,4R)-3-[3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl]-N-(pyridin-3-ylmethyl)bicyclo[2.2.1]heptane-2-carboxamide is O=C(NCc1cccnc1)[C@H]1[C@H]2CC[C@H](C2)[C@@H]1c1nc(COc2ccccc2)no1.
What is the InChIKey of (1S,2S,3S,4R)-3-[3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl]-N-(pyridin-3-ylmethyl)bicyclo[2.2.1]heptane-2-carboxamide?
The InChIKey is HEEKTMQRLKRHIL-JWWGGVBKSA-N. The full InChI is InChI=1S/C23H24N4O3/c28-22(25-13-15-5-4-10-24-12-15)20-16-8-9-17(11-16)21(20)23-26-19(27-30-23)14-29-18-6-2-1-3-7-18/h1-7,10,12,16-17,20-21H,8-9,11,13-14H2,(H,25,28)/t16-,17+,20-,21-/m0/s1.
What are the key properties of (1S,2S,3S,4R)-3-[3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl]-N-(pyridin-3-ylmethyl)bicyclo[2.2.1]heptane-2-carboxamide?
(1S,2S,3S,4R)-3-[3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl]-N-(pyridin-3-ylmethyl)bicyclo[2.2.1]heptane-2-carboxamide has a molecular weight of 404.47 g/mol, XLogP of 3.49, 7 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,2S,3S,4R)-3-[3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl]-N-(pyridin-3-ylmethyl)bicyclo[2.2.1]heptane-2-carboxamide is sourced from PubChem (CID 171336851), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).